Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · IEX Real-Time Price · USD
6.21
-0.37 (-5.62%)
At close: Apr 12, 2024, 4:00 PM
6.24
+0.03 (0.48%)
After-hours: Apr 12, 2024, 7:59 PM EDT

Editas Medicine Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Revenue
78.1219.7125.5490.7320.5331.9413.736.051.630
Revenue Growth (YoY)
296.32%-22.83%-71.85%341.93%-35.71%132.64%126.80%271.58%--
Gross Profit
78.1219.7125.5490.7320.5331.9413.736.051.630
Selling, General & Admin
69.6570.776.1867.5864.5655.0150.546.2618.17.65
Research & Development
177.65174.96142.5115896.990.6583.1656.9818.855.07
Operating Expenses
247.3245.66218.69225.57161.45145.66133.66103.2436.9412.72
Operating Income
-169.18-225.95-193.15-134.84-140.92-113.73-119.93-97.19-35.31-12.72
Interest Expense / Income
-17.57-5.52-0.61-2.61-7.31-3.450.98-0.060.140.03
Other Expense / Income
1.6--0.04-16.260.14-0.33-0.590.0637.450.93
Pretax Income
-153.22-220.43-192.5-115.98-133.75-109.95-120.32-97.18-72.9-13.69
Net Income
-153.22-220.43-192.5-115.98-133.75-109.95-120.32-97.18-72.9-13.69
Preferred Dividends
00000000.050.390.31
Net Income Common
-153.22-220.43-192.5-115.98-133.75-109.95-120.32-97.23-73.29-13.99
Shares Outstanding (Basic)
766968595047403231
Shares Outstanding (Diluted)
766968595047403231
Shares Change
10.63%1.55%15.37%17.26%6.13%16.80%25.15%1155.19%128.56%-
EPS (Basic)
-2.02-3.21-2.85-1.98-2.68-2.33-2.98-3.02-28.55-12.46
EPS (Diluted)
-2.02-3.21-2.85-1.98-2.68-2.33-2.98-3.02-28.55-12.46
Free Cash Flow
-136.9-181.45-171.78-186.99-46.73-50.42-11.46-53.72-6.87-9.87
Free Cash Flow Per Share
-1.80-2.64-2.54-3.19-0.94-1.07-0.28-1.67-2.68-8.79
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-216.56%-1146.26%-756.13%-148.61%-686.39%-356.10%-873.64%-1605.62%-2167.71%-
Profit Margin
-196.13%-1118.26%-753.61%-127.82%-651.43%-344.28%-876.49%-1606.31%-4499.32%-
Free Cash Flow Margin
-175.23%-920.50%-672.49%-206.09%-227.63%-157.89%-83.49%-887.48%-421.98%-
EBITDA
-164.72-219.61-188.06-114.62-138.23-110.15-116.66-96.04-72.29-13.49
EBITDA Margin
-210.85%-1114.11%-736.20%-126.33%-673.27%-344.88%-849.82%-1586.70%-4437.45%-
Depreciation & Amortization
6.066.345.053.962.833.252.681.20.470.16
EBIT
-170.79-225.95-193.11-118.58-141.06-113.4-119.35-97.25-72.76-13.65
EBIT Margin
-218.61%-1146.26%-755.99%-130.69%-687.05%-355.07%-869.36%-1606.56%-4466.36%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).